Back60 Degrees Pharmaceuticals Overview

60 Degrees Pharmaceuticals Receivables

60 Degrees Pharmaceuticals's receivables is $340K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$335836.00
31.22% YoYΔ $-152407.00 vs prior year quarter

Peer average

Loading

60 Degrees Pharmaceuticals Receivables History

Loading

60 Degrees Pharmaceuticals vs. peers: Receivables Comparison

Loading

60 Degrees Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

60 Degrees Pharmaceuticals (SXTP) FAQ

As of the most recent data (March 2026), SXTP shows a receivables of $340K. That compares with $490K in the prior-year period — down 31.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SXTP's receivables is now $340K (was $490K) — a 31.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 60 Degrees Pharmaceuticals is outperforming or lagging.

Tracking SXTP's receivables over time shows whether 60 Degrees Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $340K That compares with $490K in the prior-year period — down 31.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has 60 Degrees Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $340K) with ownership activity and broader fundamentals.